Chemistry Cascades: Synthesis of prostratin analogues for evaluation against HIV

化学级联:合成前列腺素类似物以评估抗 HIV 效果

基本信息

  • 批准号:
    EP/I004017/1
  • 负责人:
  • 金额:
    $ 37.96万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2010
  • 资助国家:
    英国
  • 起止时间:
    2010 至 无数据
  • 项目状态:
    已结题

项目摘要

In the field of healthcare, there are few greater challenges than the continuing fight against HIV and AIDS. In this war, we look to nature for inspiration in the design of new therapeutics as natural products often have complex molecular architectures that have evolved over millennia to act as selective ligands for biological targets. For example, naturally occuring phorbol esters are amongst the most potent of tumour promoters and have proved useful 'small molecule' tools for the study of carcinogenesis and the development of methods for its prevention. The discovery that natural compounds related to phorbol, such as the non-tumour promoting natural product prostratin, are active against latent HIV is the most exciting recent development in the biology of this compound class. In fact, prostratin promises a major advance in approaches to deplete viral reservoirs and has caused significant excitement in recent years. Latent HIV viral reservoirs persist after treatment of HIV-infected patients using current therapies, thus preventing elimination of the virus. Prostratin functions by flushing 'hibernating' HIV out of resting T-cells so that antiretroviral drugs can attack.Unfortunately, the levels of prostratin found in the source plants is very low and limited access to the natural product has slowed its development as a therapeutic agent. This poses the question: if we can't isolate what we need from nature, can we synthesise these substances efficiently in the laboratory? Unfortunately, natural products related to phorbol are very difficult to prepare using the current state-of-the-art synthetic tools. In fact, the only reported synthesis of phorbol took 52 chemical steps! The only attempt to prepare prostratin to date has started from the scarce natural product phorbol. Not only is this an unsatisfactory solution to the supply problem, but a 'top-down' synthesis such as this does not facilitate fundamental changes to the interior of the molecule and we learn little about the effect of modifying the natural product's core structure. The development of an efficient synthesis of prostratin from scratch is a timely challenge and will address the issue of supply and will allow the preparation of analogues of prostratin that are urgently needed but are currently unobtainable.In this project we will develop selective reactions in which simple starting materials 'cascade' through to complex molecules in a single step, using a single reagent. Not only will the cascade reactions grant us rapid access to the targets but they will also allow us to control the shape, or stereochemistry, of the molecule under construction. The new synthetic tools developed will allow us to carry out the first synthesis of prostratin and analogues of the natural product that will prove valuable weapons in the fight against HIV and AIDS. In addition, the new synthetic methods we create will allow chemists to streamline routes when designing syntheses in the future, thus shortening processes and minimising waste. Such improvements in the way we build molecules are urgently needed by the scientific community.
在保健领域,没有什么比继续防治艾滋病毒和艾滋病更大的挑战了。在这场战争中,我们在设计新疗法时向大自然寻求灵感,因为天然产品通常具有复杂的分子结构,这些分子结构已经进化了数千年,可作为生物靶点的选择性配体。例如,天然存在的佛波醇酯是最有效的肿瘤促进剂之一,并已被证明是研究致癌作用和开发预防方法的有用的“小分子”工具。与佛波醇相关的天然化合物,如非肿瘤促进天然产物prostratin,对潜伏的HIV有活性的发现是这类化合物生物学中最令人兴奋的最新发展。事实上,prostratin有望在耗尽病毒库的方法上取得重大进展,近年来引起了极大的兴奋。潜伏的HIV病毒库在使用当前疗法治疗HIV感染患者后持续存在,从而阻止病毒的消除。Prostratin的功能是将“冬眠”的HIV从休眠的T细胞中冲洗出来,这样抗逆转录病毒药物就可以攻击它。不幸的是,在来源植物中发现的prostratin水平非常低,而且这种天然产物的获取有限,减缓了它作为治疗剂的发展。这就提出了一个问题:如果我们不能从自然界中分离出我们需要的物质,我们能在实验室中有效地合成这些物质吗?不幸的是,与佛波醇相关的天然产物很难使用目前最先进的合成工具制备。事实上,唯一报道的佛波醇合成需要52个化学步骤!迄今为止,制备prostratin的唯一尝试是从稀缺的天然产物佛波醇开始。这不仅是供应问题的一个不满意的解决方案,而且像这样的“自上而下”的合成并不能促进分子内部的根本变化,而且我们对修改天然产物核心结构的影响知之甚少。从零开始有效合成prostratin的发展是一个及时的挑战,将解决供应问题,并将允许制备prostratin的类似物,迫切需要,但目前无法获得。在这个项目中,我们将开发选择性反应,其中简单的起始材料“级联”通过复杂的分子在一个步骤中,使用单一的试剂。级联反应不仅使我们能够快速接近目标,而且还使我们能够控制正在构建的分子的形状或立体化学。开发的新合成工具将使我们能够首次合成prostratin和这种天然产物的类似物,这将证明是防治艾滋病毒和艾滋病的宝贵武器。此外,我们创造的新合成方法将使化学家在未来设计合成时能够简化路线,从而缩短流程并最大限度地减少浪费。科学界迫切需要改进我们构建分子的方式。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Structural analysis and reactivity of unusual tetrahedral intermediates enabled by SmI2-mediated reduction of barbituric acids: vinylogous N-acyliminium additions to a-hydroxy-N-acyl-carbamides.
由 SmI2 介导的巴比妥酸还原实现的不寻常四面体中间体的结构分析和反应性:插烯 N-酰亚胺加成到 a-羟基-N-酰基-脲。
Substrate-Directable Electron-Transfer Reactions. Dramatic Rate Enhancement in the Chemoselective Reduction of Cyclic Esters Using SmI
底物可定向电子转移反应。
  • DOI:
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    2.6
  • 作者:
    Spain Malcolm
  • 通讯作者:
    Spain Malcolm
On the role of pre- and post-electron-transfer steps in the SmI2 /amine/H(2)O-mediated reduction of esters: new mechanistic insights and kinetic studies.
  • DOI:
    10.1002/chem.201400295
  • 发表时间:
    2014-04-07
  • 期刊:
  • 影响因子:
    4.3
  • 作者:
    Szostak, Michal;Spain, Malcolm;Procter, David J.
  • 通讯作者:
    Procter, David J.
Concise syntheses of strychnine and englerin A: the power of reductive cyclizations triggered by samarium iodide.
  • DOI:
    10.1002/anie.201103128
  • 发表时间:
    2011-08
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Szostak;D. Procter
  • 通讯作者:
    M. Szostak;D. Procter
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David Procter其他文献

A Stereoselective Cyclization Cascade Mediated by SmI_2-H_2O : Synthetic Studies towards Stolonidiol
SmI_2-H_2O 介导的立体选择性环化级联:斯托洛尼醇的合成研究
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Thomas Baker;Lisa Sloan;Masahito Murai;David Procter
  • 通讯作者:
    David Procter

David Procter的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David Procter', 18)}}的其他基金

Relaying radicals for catalytic couplings: Catalysis with SmI2
催化偶联的中继自由基:SmI2 催化
  • 批准号:
    EP/W016354/1
  • 财政年份:
    2022
  • 资助金额:
    $ 37.96万
  • 项目类别:
    Research Grant
Sulfoxides as substrate activators: New cross-couplings for making materials and medicines
亚砜作为底物活化剂:用于制造材料和药物的新交叉偶联
  • 批准号:
    EP/T013419/1
  • 财政年份:
    2020
  • 资助金额:
    $ 37.96万
  • 项目类别:
    Research Grant
Complex made simple: Enantioselective radical cascades mediated by SmI2
复杂变得简单:SmI2 介导的对映选择性自由基级联
  • 批准号:
    EP/R029938/1
  • 财政年份:
    2018
  • 资助金额:
    $ 37.96万
  • 项目类别:
    Research Grant
Metal-free couplings for molecules, materials and bioactive targets
用于分子、材料和生物活性靶标的无金属耦合
  • 批准号:
    EP/M005062/1
  • 财政年份:
    2015
  • 资助金额:
    $ 37.96万
  • 项目类别:
    Fellowship
Cyclizations and cyclization cascades triggered by new reductions
新还原引发的环化和环化级联
  • 批准号:
    EP/L00125X/1
  • 财政年份:
    2013
  • 资助金额:
    $ 37.96万
  • 项目类别:
    Research Grant
Under water control: A cascade approach to the pseudolaric acid anti-tumour agents
水控制下:拟月桂酸抗肿瘤剂的级联方法
  • 批准号:
    EP/H008691/1
  • 财政年份:
    2009
  • 资助金额:
    $ 37.96万
  • 项目类别:
    Research Grant
The on-off switch: Synthesis of functional heterocycles mediated by the capture and release of thiols
开关:通过硫醇的捕获和释放介导功能性杂环的合成
  • 批准号:
    EP/G015287/1
  • 财政年份:
    2008
  • 资助金额:
    $ 37.96万
  • 项目类别:
    Research Grant
Waiting in line: A sequenced approach to the antibacterial pleuromutilin
排队等候:抗菌截短侧耳素的有序治疗方法
  • 批准号:
    EP/E021220/1
  • 财政年份:
    2007
  • 资助金额:
    $ 37.96万
  • 项目类别:
    Research Grant

相似海外基金

Total Synthesis of Dodecahedrane via Carbon–Carbon Bond Forming Cascades
通过碳-碳键形成级联全合成十二面体
  • 批准号:
    10679420
  • 财政年份:
    2023
  • 资助金额:
    $ 37.96万
  • 项目类别:
Anionic and Pericyclic Reaction Cascades for Organic Synthesis
用于有机合成的阴离子和周环反应级联
  • 批准号:
    2153657
  • 财政年份:
    2022
  • 资助金额:
    $ 37.96万
  • 项目类别:
    Standard Grant
Chemo-Divergent Cationic Cascades for the Synthesis of Biologically Active Alkaloids
用于合成生物活性生物碱的化学发散阳离子级联
  • 批准号:
    10388002
  • 财政年份:
    2022
  • 资助金额:
    $ 37.96万
  • 项目类别:
Chemo-Divergent Cationic Cascades for the Synthesis of Biologically Active Alkaloids
用于合成生物活性生物碱的化学发散阳离子级联
  • 批准号:
    10615674
  • 财政年份:
    2022
  • 资助金额:
    $ 37.96万
  • 项目类别:
Aza-Heck/C-C cleavage/cross coupling cascades of pinene derivatives for the synthesis of zoanthamine alkaloids
蒎烯衍生物的 Aza-Heck/C-C 裂解/交叉偶联级联用于合成佐安胺生物碱
  • 批准号:
    10328890
  • 财政年份:
    2021
  • 资助金额:
    $ 37.96万
  • 项目类别:
Aza-Heck/C-C cleavage/cross coupling cascades of pinene derivatives for the synthesis of zoanthamine alkaloids
蒎烯衍生物的 Aza-Heck/C-C 裂解/交叉偶联级联用于合成佐安胺生物碱
  • 批准号:
    10540775
  • 财政年份:
    2021
  • 资助金额:
    $ 37.96万
  • 项目类别:
Alkaloids synthesis via enzymatic cascades
通过酶级联合成生物碱
  • 批准号:
    2505628
  • 财政年份:
    2020
  • 资助金额:
    $ 37.96万
  • 项目类别:
    Studentship
New Reaction Cascades for Organic Synthesis
有机合成的新级联反应
  • 批准号:
    1855708
  • 财政年份:
    2019
  • 资助金额:
    $ 37.96万
  • 项目类别:
    Standard Grant
KRED-Origami: Synthesis and Characterization of Ketoreductase Cascades Assembled on DNA Origami Nanostructures
KRED-Origami:DNA 折纸纳米结构上组装的酮还原酶级联的合成和表征
  • 批准号:
    335742134
  • 财政年份:
    2017
  • 资助金额:
    $ 37.96万
  • 项目类别:
    Research Grants
New methodologies for hydrogen borrowing cascades in the synthesis of amine scaffolds and its application in Natural product and drug synthesis
胺支架合成中的借氢级联新方法及其在天然产物和药物合成中的应用
  • 批准号:
    1923106
  • 财政年份:
    2017
  • 资助金额:
    $ 37.96万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了